BCR ABL Quantitative RT-PCR Kit - Major, Minor, Micro

Features & Benefits

• Evaluates the molecular response up to 5 log reduction which is undetectable BCR-ABL1.

• The reporting is based on European Treatment and Outcome Study (EUTOS) guidelines and European Leukemia Net (ELN) recommendations

• The quantitation standards provided are with known copy numbers and are calibrated against WHO 1st International Genetic Reference

• Panel for the quantitation of BCR-ABL1 translocation (09/138) for assigning IS values to a measured level of BCR ABL/ABL %.

• The minor BCR-ABL1 and micro BCR-ABL1 are reported in NCN%.

• The kit supports reverse transcription. No additional cDNA steps are required.

• High-Quality Mastermix shows Increased Inhibitor Tolerance, Thermostability, and Reproducibility.

• Diagnosis of Chronic Myeloid Leukemia and Ph-Positive Acute Lymphoblastic Leukemia. See if cancer treatment is effective. Treatment response by Log reduction (4.5 log reduction) is monitored. See if a patient has developed resistance to certain treatments.